[{"Assets_0_Q1_USD":142338000.0,"CommonStockSharesOutstanding_0_Q1_shares":110270000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-26998000.0,"NetIncomeLoss_1_Q1_USD":-31054000.0,"StockholdersEquity_0_Q1_USD":22507000.0,"Ticker":"BCRX","CIK":"882796","name":"BIOCRYST PHARMACEUTICALS INC","OfficialName":"BioCryst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1887243586.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190509"}]